Progress in personalized immunotherapy for patients with brain metastasis

Lalit Patel1, Nikola Kolundzic2,3, Malak Abedalthagafi4

  • 1Department of Pathology and Lab Medicine, Emory University School of Medicine, Atlanta, GA, USA.

NPJ Precision Oncology
|January 29, 2025
PubMed

Brain metastasis leads to poor outcomes and CNS injury, significantly reducing quality of life and survival rates. Advances in understanding the tumor immune microenvironment have revealed the promise of immunotherapies, which, alongside surgery, chemotherapy, and radiation, offer improved survival for some patients. However, resistance to immunotherapy remains a critical challenge. This review explores the immune landscape of brain metastases, current therapies, clinical trials, and the need for personalized, biomarker-driven approaches to optimize outcomes.

Related Concept Videos